Apyx Medical Corporation (APYX)
USD 1.0
(-13.79%)
USD 1.0
(-13.79%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 33.18 Million USD | 6011.42% |
| 2022 | 543 Thousand USD | 2916.67% |
| 2021 | 18 Thousand USD | -94.23% |
| 2020 | 312 Thousand USD | -52.44% |
| 2019 | 656 Thousand USD | 368.57% |
| 2018 | 140 Thousand USD | -94.61% |
| 2017 | 2.59 Million USD | -8.43% |
| 2016 | 2.83 Million USD | -7.81% |
| 2015 | 3.07 Million USD | -3.12% |
| 2014 | 3.17 Million USD | -0.38% |
| 2013 | 3.18 Million USD | -2.93% |
| 2012 | 3.28 Million USD | -9.59% |
| 2011 | 3.62 Million USD | -6.57% |
| 2010 | 3.88 Million USD | -1.87% |
| 2009 | 3.95 Million USD | 2.15% |
| 2008 | 3.87 Million USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 348.32 Thousand USD | -8.33% |
| 2003 | 379.99 Thousand USD | -7.69% |
| 2002 | 411.66 Thousand USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | -100.0% |
| 1998 | 11.22 Thousand USD | -84.85% |
| 1997 | 74.1 Thousand USD | -84.65% |
| 1996 | 482.7 Thousand USD | -25.49% |
| 1995 | 647.8 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 33.62 Million USD | 0.66% |
| 2024 Q1 | 33.4 Million USD | 0.67% |
| 2023 Q2 | 5.15 Million USD | 899.22% |
| 2023 Q4 | 33.18 Million USD | 136.04% |
| 2023 Q1 | 516 Thousand USD | -4.97% |
| 2023 FY | 33.18 Million USD | 6011.42% |
| 2023 Q3 | 14.05 Million USD | 172.67% |
| 2022 Q1 | 13 Thousand USD | -27.78% |
| 2022 Q2 | 607 Thousand USD | 4569.23% |
| 2022 Q3 | 532 Thousand USD | -12.36% |
| 2022 Q4 | 543 Thousand USD | 2.07% |
| 2022 FY | 543 Thousand USD | 2916.67% |
| 2021 Q4 | 18 Thousand USD | -65.38% |
| 2021 FY | 18 Thousand USD | -94.23% |
| 2021 Q1 | 201 Thousand USD | -35.58% |
| 2021 Q2 | 139 Thousand USD | -30.85% |
| 2021 Q3 | 52 Thousand USD | -62.59% |
| 2020 Q1 | 565 Thousand USD | -13.87% |
| 2020 Q2 | 591 Thousand USD | 4.6% |
| 2020 Q3 | 500 Thousand USD | -15.4% |
| 2020 Q4 | 312 Thousand USD | -37.6% |
| 2020 FY | 312 Thousand USD | -52.44% |
| 2019 FY | 656 Thousand USD | 368.57% |
| 2019 Q4 | 656 Thousand USD | -21.15% |
| 2019 Q3 | 832 Thousand USD | 104.42% |
| 2019 Q2 | 407 Thousand USD | 89.3% |
| 2019 Q1 | 215 Thousand USD | 53.57% |
| 2018 Q1 | 2.53 Million USD | -2.31% |
| 2018 FY | 140 Thousand USD | -94.61% |
| 2018 Q4 | 140 Thousand USD | 0.0% |
| 2018 Q3 | 140 Thousand USD | -94.34% |
| 2018 Q2 | 2.47 Million USD | -2.37% |
| 2017 Q2 | 2.71 Million USD | -2.16% |
| 2017 Q3 | 2.65 Million USD | -2.21% |
| 2017 Q4 | 2.59 Million USD | -2.26% |
| 2017 FY | 2.59 Million USD | -8.43% |
| 2017 Q1 | 2.77 Million USD | -2.08% |
| 2016 FY | 2.83 Million USD | -7.81% |
| 2016 Q1 | 140 Thousand USD | -95.45% |
| 2016 Q2 | 2.95 Million USD | 2010.0% |
| 2016 Q3 | 2.89 Million USD | -2.03% |
| 2016 Q4 | 2.83 Million USD | -2.07% |
| 2015 FY | 3.07 Million USD | -3.12% |
| 2015 Q3 | 2.99 Million USD | -1.93% |
| 2015 Q2 | 3.05 Million USD | -1.93% |
| 2015 Q1 | 3.11 Million USD | -1.89% |
| 2015 Q4 | 3.07 Million USD | 2.67% |
| 2014 Q4 | 3.17 Million USD | -1.83% |
| 2014 Q3 | 3.23 Million USD | -1.85% |
| 2014 Q2 | 3.29 Million USD | -1.79% |
| 2014 FY | 3.17 Million USD | -0.38% |
| 2014 Q1 | 3.35 Million USD | 5.27% |
| 2013 Q1 | 3.24 Million USD | -1.1% |
| 2013 Q3 | 3.03 Million USD | -5.58% |
| 2013 Q4 | 3.18 Million USD | 5.12% |
| 2013 FY | 3.18 Million USD | -2.93% |
| 2013 Q2 | 3.2 Million USD | -1.11% |
| 2012 Q4 | 3.28 Million USD | -1.77% |
| 2012 FY | 3.28 Million USD | -9.59% |
| 2012 Q1 | 3.52 Million USD | -2.89% |
| 2012 Q2 | 93 Thousand USD | -97.36% |
| 2012 Q3 | 3.34 Million USD | 3491.4% |
| 2011 Q2 | 3.63 Million USD | -1.03% |
| 2011 FY | 3.62 Million USD | -6.57% |
| 2011 Q4 | 3.62 Million USD | 0.72% |
| 2011 Q3 | 3.6 Million USD | -0.99% |
| 2011 Q1 | 3.67 Million USD | -5.33% |
| 2010 Q1 | 3.92 Million USD | -0.85% |
| 2010 FY | 3.88 Million USD | -1.87% |
| 2010 Q3 | 3.63 Million USD | -0.92% |
| 2010 Q4 | 3.88 Million USD | 6.74% |
| 2010 Q2 | 3.67 Million USD | -6.42% |
| 2009 Q2 | 4.08 Million USD | -0.76% |
| 2009 FY | 3.95 Million USD | 2.15% |
| 2009 Q3 | 4.04 Million USD | -0.96% |
| 2009 Q4 | 3.95 Million USD | -2.06% |
| 2009 Q1 | 4.11 Million USD | 6.11% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | 3.87 Million USD | 0.0% |
| 2008 FY | 3.87 Million USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 Q3 | 324.57 Thousand USD | -2.38% |
| 2005 Q4 | - USD | -100.0% |
| 2005 Q2 | 332.49 Thousand USD | -4.46% |
| 2005 Q1 | 348 Thousand USD | -0.09% |
| 2005 FY | - USD | -100.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | -100.0% |
| 2004 Q4 | 348.32 Thousand USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 FY | 348.32 Thousand USD | -8.33% |
| 2003 FY | 379.99 Thousand USD | -7.69% |
| 2003 Q1 | 403.74 Thousand USD | -1.92% |
| 2003 Q4 | 379.99 Thousand USD | -2.04% |
| 2003 Q3 | 387.91 Thousand USD | 0.0% |
| 2003 Q2 | - USD | -100.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q4 | 411.66 Thousand USD | 0.0% |
| 2002 FY | 411.66 Thousand USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 1999 FY | - USD | -100.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1998 Q1 | - USD | -100.0% |
| 1998 Q2 | 3 Million USD | 0.0% |
| 1998 Q3 | - USD | -100.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | 11.22 Thousand USD | -84.85% |
| 1997 Q2 | 600 Thousand USD | 0.0% |
| 1997 Q1 | 600 Thousand USD | 20.0% |
| 1997 Q4 | 100 Thousand USD | 0.0% |
| 1997 FY | 74.1 Thousand USD | -84.65% |
| 1997 Q3 | 100 Thousand USD | -83.33% |
| 1996 Q2 | 500 Thousand USD | -16.67% |
| 1996 FY | 482.7 Thousand USD | -25.49% |
| 1996 Q3 | 500 Thousand USD | 0.0% |
| 1996 Q1 | 600 Thousand USD | 0.0% |
| 1996 Q4 | 500 Thousand USD | 0.0% |
| 1995 Q4 | 600 Thousand USD | 0.0% |
| 1995 FY | 647.8 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 8.08% |
| BrainsWay Ltd. | 239 Thousand USD | -13784.937% |
| Cerus Corporation | 59.79 Million USD | 44.503% |
| Envoy Medical, Inc. | 404 Thousand USD | -8114.109% |
| electroCore, Inc. | 537 Thousand USD | -6079.702% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -276441.667% |
| IceCure Medical Ltd | 376 Thousand USD | -8725.798% |
| Inogen, Inc. | 18.27 Million USD | -81.637% |
| OrthoPediatrics Corp. | 13.45 Million USD | -146.564% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -16575.879% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -9023.676% |
| MaxCyte, Inc. | 17.96 Million USD | -84.679% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -59926.409% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 64.358% |
| PAVmed Inc | 2.96 Million USD | -1021.115% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -434.036% |
| RxSight, Inc. | 1.21 Million USD | -2640.297% |
| Sight Sciences, Inc. | 31.7 Million USD | -4.658% |
| SI-BONE, Inc. | 36.06 Million USD | 7.986% |
| TELA Bio, Inc. | 40.51 Million USD | 18.092% |
| Treace Medical Concepts, Inc. | 53 Million USD | 37.396% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -2081.788% |
| Acutus Medical, Inc. | 32.65 Million USD | -1.626% |
| Talis Biomedical Corporation | 16.78 Million USD | -97.695% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -720.396% |
| CVRx, Inc. | 30.38 Million USD | -9.226% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -3163.253% |
| Bioventus Inc. | 366.99 Million USD | 90.958% |
| Venus Concept Inc. | 70.79 Million USD | 53.122% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -2567.605% |
| LivaNova PLC | 568.54 Million USD | 94.163% |
| 908 Devices Inc. | 3.92 Million USD | -744.617% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 93.506% |
| Nemaura Medical Inc. | 3.08 Million USD | -974.765% |
| NeuroPace, Inc. | 56.95 Million USD | 41.734% |
| LENSAR, Inc. | 1.75 Million USD | -1796.286% |
| Cutera, Inc. | 418.69 Million USD | 92.074% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -120.586% |
| BioSig Technologies, Inc. | 103 Thousand USD | -32118.447% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -23.346% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -233.551% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 97.765% |
| Axonics, Inc. | 25.84 Million USD | -28.425% |
| Outset Medical, Inc. | 134.59 Million USD | 75.345% |
| IRIDEX Corporation | 1.75 Million USD | -1795.203% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 35.361% |
| IRadimed Corporation | 1.61 Million USD | -1954.697% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -18755.114% |
| INVO Bioscience, Inc. | 6.77 Million USD | -389.737% |
| Telesis Bio, Inc. | 5.26 Million USD | -529.816% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -455.742% |
| Varex Imaging Corporation | 464.2 Million USD | 92.851% |
| Quipt Home Medical Corp. | 60.82 Million USD | 45.438% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -5543.707% |
| Pulmonx Corporation | 35.08 Million USD | 5.426% |
| Dynatronics Corporation | 3.25 Million USD | -918.42% |
| Modular Medical, Inc. | 817 Thousand USD | -3961.812% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -21876.821% |
| Semler Scientific, Inc. | 70 Thousand USD | -47307.143% |
| InMode Ltd. | 6.61 Million USD | -401.815% |
| Bruker Corporation | 1.14 Billion USD | 97.1% |
| Cytosorbents Corporation | 2.54 Million USD | -1205.028% |
| DexCom, Inc. | 2.57 Billion USD | 98.71% |
| Align Technology, Inc. | 96.96 Million USD | 65.777% |
| Viveve Medical, Inc. | 5.12 Million USD | -547.639% |
| ZimVie Inc. | 508.79 Million USD | 93.478% |
| Movano Inc. | 15.00 USD | -221233233.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -83.09% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 91.675% |
| Profound Medical Corp. | 4.97 Million USD | -567.113% |
| Insulet Corporation | 1.36 Billion USD | 97.571% |
| enVVeno Medical Corporation | 1.06 Million USD | -3018.891% |
| Surmodics, Inc. | 29.4 Million USD | -12.855% |
| iCAD, Inc. | 273 Thousand USD | -12055.678% |
| Nuwellis, Inc. | 221 Thousand USD | -14915.837% |
| Biotricity, Inc. | 10.85 Million USD | -205.688% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 5.05% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -5007.341% |
| InspireMD, Inc. | 1.03 Million USD | -3097.013% |
| PAVmed Inc. | 2.96 Million USD | -1021.115% |
| BIOLASE, Inc. | 13.98 Million USD | -137.29% |
| Beyond Air, Inc. | 14.72 Million USD | -125.426% |
| FONAR Corporation | 37.92 Million USD | 12.509% |
| AxoGen, Inc. | 46.6 Million USD | 28.792% |
| Vivani Medical, Inc. | 19.31 Million USD | -71.827% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 25.614% |
| Inari Medical, Inc. | 30.35 Million USD | -9.323% |
| UFP Technologies, Inc. | 28 Million USD | -18.518% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -7545.521% |
| Tenon Medical, Inc. | 428 Thousand USD | -7653.505% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -3211.876% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -1441.925% |
| AdaptHealth Corp. | 2.09 Billion USD | 98.416% |
| Sintx Technologies, Inc. | 3.68 Million USD | -800.054% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 10.848% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -5543.707% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -5467.953% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 96.281% |
| TransMedics Group, Inc. | 506.2 Million USD | 93.444% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -5367.051% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -35781.494% |
| Hyperfine, Inc. | 64 Thousand USD | -51751.563% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 82.418% |
| Biomerica, Inc. | 459 Thousand USD | -7129.847% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -7282.927% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -17366.985% |
| Silk Road Medical, Inc | 75.62 Million USD | 56.12% |